Relationship between SU subdomains that regulate the receptor-mediated transition from the native (fusion-inhibited) to the fusion-active conformation of the murine leukemia virus glycoprotein

Journal of Virology

Volumn 76, Issue 19, 2002, Pages 9673-9685

  Lavillette, Dimitri ^a   Ruggieri, Alessia ^a   Boson, Bertrand ^a   Maurice, Marielle ^a   Cosset, François Loïc ^a  

^a UNIVERSITÉ DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROLINE; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN; VIRUS RECEPTOR;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CIS TRANS ISOMERISM; CONFORMATIONAL TRANSITION; HUMAN; HUMAN CELL; MURINE LEUKEMIA VIRUS; MUTATION; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; RECEPTOR BINDING; RETROVIRUS; VIRION;

BINDING SITES; HUMANS; LEUKEMIA VIRUS, MURINE; MEMBRANE FUSION; PROTEIN CONFORMATION; RECEPTORS, VIRUS; TUMOR CELLS, CULTURED; VIRAL ENVELOPE PROTEINS;

EID: 0036776515     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.19.9673-9685.2002     Document Type: Article

References (62)

1. In vitro cell-free conversion of noninfectious Moloney retrovirus particles to an infectious form by the addition of the vesicular stomatitis virus surrogate envelope G protein
2. Identification of a cellular cofactor required for infection by feline leukemia virus
3. Functional dissection of the Moloney murine leukemia virus envelope protein gp70
4. Receptor binding transforms the surface subunit of the mammalian C-type retrovirus envelope protein from an inhibitor to an activator of fusion
5. Modular organization of the Friend murine leukemia virus envelope protein underlies the mechanism of infection
6. Adaptation of chimeric retroviruses in vitro and in vivo: Isolation of avian retroviral vectors with extended host range
7. An envelope glycoprotein of the human endogenous retrovirus HERV-W is expressed in human placenta and fuses cells expressing the type D mammalian retrovirus receptor
8. Retrotransposons, endogenous retroviruses, and the evolution of retroelements
9. +-T-cell depletion in human lymphoid tissue, a major site of replication in vivo
10. Postassembly cleavage of a retroviral glycoprotein cytoplasmic domain removes a necessary incorporation signal and activates fusion activity
11. A viral protease-mediated cleavage of the transmembrane glycoprotein of Mason-Pfizer monkey virus can be suppressed by mutations within the matrix protein
12. Influenza hemagglutinin is spring-loaded by a metastable native conformation
13. Structure of the hemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation
14. Induction of syncytia by neuropathogenic murine leukemia viruses depends on receptor density, host cell determinants, and the intrinsic fusion potential of envelope protein
15. Retroviral retargeting by envelopes expressing an N-terminal binding domain
16. High-titer packaging cells producing recombinant retroviruses resistant to human serum
17. Influence of transmembrane domains on the fusogenic abilities of human and murine leukemia retrovirus envelopes
18. Mechanisms of viral membrane fusion and its inhibition
19. Structure of a murine leukemia virus receptor binding glycoprotein at 2.0 Å resolution
20. Interaction between virion-bound host intercellular adhesion molecule-1 and the high-affinity state of lymphocyte function-associated antigen-1 on target cells renders R5 and X4 isolates of human immunodeficiency virus type 1 more refractory to neutralization
21. Host-derived ICAM-1 glycoproteins incorporated on human immunodeficiency virus type 1 are biologically active and enhance viral infectivity
22. Mutational analysis of the envelope gene of Moloney murine leukemia virus
23. Feline leukemia virus envelope sequences that affect T-cell tropism and syncytium formation are not part of known receptor binding domains
24. Enveloped viruses: A common mode of membrane fusion?
25. Viral entry and receptors
26. Fv-4 resistance gene: A truncated endogenous murine leukemia virus with ecotropic interference properties
27. Rapid and efficient purification of native histidine-tagged protein expressed by recombinant vaccinia virus
28. The hypevariable domain of the murine leukemia virus surface protein tolerates large insertions and deletions, enabling development of a retroviral particle display system
29. Crystal structure of human T cell leukemia virus type 1 gp21 ectodomain crystallized as a maltose-binding protein chimera reveals structural evolution of retroviral transmembrane proteins
30. The envelope glycoprotein of an amphotropic murine retrovirus binds specifically to the cellular receptor/phosphate transporter of susceptible species
31. Paramyxovirus fusion: A hypothesis for changes
32. Membrane fusion by murine leukemia viruses is activated in cis or in trans by interactions of the receptor binding domain with a conserved disulfide loop at the carboxy terminus of the surface glycoproteins
33. A proline-rich motif downstream of the receptor binding domain modulates conformation and fusogenicity of murine retroviral envelopes
34. Activation of a cell entry pathway common to type C mammalian retroviruses by soluble envelope fragments
35. Cytosolic Gag p24 as an index of productive entry of human immunodeficiency virus type 1
36. Human immunodeficiency virus type 1 entry into macrophages mediated by macropinocytosis
37. The pH independence of mammalian retrovirus infection
38. Role of the cytoplasmic tail of ecotropic Moloney murine leukemia virus Env protein in fusion pore formation
39. Human immunodeficiency virus type 1 attachment to HeLa CD4 cells is CD4 independent and gp120 dependent and requires cell surface heparans
40. The three faces of paramyxovirus attachment proteins
41. Sequences determining the pH dependence of viral entry are distinct from the host range-determining region of the murine ecotropic and amphotropic retrovirus envelope proteins
42. Second-site changes affect viability of amphotropic/ecotropic chimeric enveloped murine leukemia viruses
43. Sequence analysis of amphotropic and 10A1 murine leukemia virus: Close relationship to mink cell focus-forming viruses
44. Basis for receptor specificity of nonecotropic murine leukemia virus surface glycoprotein gp70
45. Receptors and entry cofactors for retroviruses include single and multiple transmembrane-spanning proteins as well as newly described glycophosphatidylinositol-anchored and secreted proteins
46. Localization of the labile disulfide bond between SU and TM of the murine leukemia virus envelope protein complex to a highly conserved CWLC motif in SU that resembles the active-site sequence of thiol-disulfide exchange enzymes
47. The cytoplasmic domain of the human T-cell leukemia virus type I envelope can modulate envelope functions in a cell type-dependent manner
48. Evidence for nonspecific adsorption of targeted retrovirus vector particles to cells
49. Initial binding of murine leukemia virus particles to cells does not require specific Envreceptor interaction
50. pH-independent murine leukemia virus ecotropic envelope-mediated cell fusion: Implications for the role of the R peptide and p12E TM in viral entry
51. The amphotropic and ecotropic murine leukemia virus envelope TM subunits are equivalent mediators of direct membrane fusion: Implications for the role of the ecotropic envelope and receptor in syncytium formation and viral entry
52. Function of the cytoplasmic domain of a retroviral transmembrane protein: p15E-p2E cleavage activates the membrane fusion capability of the murine leukemia virus Env protein
53. Expression of endogenous ALV antigens and susceptibility to subgroup E ALV in three strains of chickens (endogenous avian C-type virus)
54. Modulation of phosphate uptake and amphotropic murine leukemia virus entry by posttranslational modifications of PIT-2
55. Separable mechanisms of attachment and cell uptake during retrovirus infection
56. Nucleotide sequence of Moloney murine leukemia virus
57. Receptor binding and membrane fusion in virus entry: The influenza hemagglutinin
58. Membrane interactions of the tick-borne encephalitis virus fusion protein E at low pH
59. Type C retrovirus inactivation by human complement is determined by both the viral genome and producer cell
60. HIV-1 attachment: Another look
61. Characterization of the proline-rich region of murine leukemia virus envelope protein
62. Suppression of a fusion defect by second-site mutations in the ecotropic murine leukemia virus surface protein